Addition of lenalidomide to melphalan in the treatment of newly diagnosed multiple myeloma: the National Cancer Institute of Canada Clinical Trials Group MY.11 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17576467

Download in:

View as

General Info

PMID
17576467